AN ACT to provide for a legislative management study regarding the regulation of cell-cultured protein.
House Bill No. 1151 mandates a legislative management study on the regulation of cell-cultured protein during the 2025-26 interim. The study will assess the current legal landscape regarding cell-cultured protein, including ongoing litigation in both federal and state courts that seeks to prohibit such products. It aims to analyze the implications of potential regulatory measures, stakeholder impacts, and the feasibility of implementing a prohibition on cell-cultured protein in North Dakota. The findings and any legislative recommendations will be reported to the seventieth legislative assembly.
If enacted, this bill will initiate a comprehensive review of the regulatory environment surrounding cell-cultured protein in North Dakota. It may influence future legislation regarding the production and sale of cell-cultured protein products, potentially aligning state regulations with those of other states or establishing unique standards. The study's outcomes could lead to significant changes in how cell-cultured proteins are treated under state law, impacting producers, consumers, and the broader agricultural sector.
The sentiment surrounding HB1151 appears to be generally supportive, as evidenced by its passage in both the House and Senate with substantial majorities (House: 84-10, Senate: 46-1). Legislators seem to recognize the importance of understanding the regulatory implications of cell-cultured protein, suggesting a proactive approach to emerging food technologies.
While there are no recorded votes against the bill, potential points of contention may arise during the study phase, particularly from stakeholders in the agricultural and food production sectors who may have differing views on the regulation of cell-cultured protein. Concerns may include economic impacts, consumer safety, and the implications for traditional protein sources.